Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 345

1.

Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations.

Rosso SM, van Herpen E, Pijnenburg YA, Schoonenboom NS, Scheltens P, Heutink P, van Swieten JC.

Arch Neurol. 2003 Sep;60(9):1209-13.

PMID:
12975285
2.

Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.

Thaweepoksomboon J, Senanarong V, Poungvarin N, Chakorn T, Siwasariyanon N, Washirutmangkur L, Udompunthuruk S.

J Med Assoc Thai. 2011 Feb;94 Suppl 1:S77-83.

PMID:
21721431
3.

Coexistent tau and amyloid pathology in hereditary frontotemporal dementia with tau mutations.

Rosso SM, Kamphorst W, Ravid R, van Swieten JC.

Ann N Y Acad Sci. 2000;920:115-9.

PMID:
11193139
4.

Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study.

Rosso SM, Donker Kaat L, Baks T, Joosse M, de Koning I, Pijnenburg Y, de Jong D, Dooijes D, Kamphorst W, Ravid R, Niermeijer MF, Verheij F, Kremer HP, Scheltens P, van Duijn CM, Heutink P, van Swieten JC.

Brain. 2003 Sep;126(Pt 9):2016-22. Epub 2003 Jul 22.

PMID:
12876142
5.

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

Buerger K, Zinkowski R, Teipel SJ, Tapiola T, Arai H, Blennow K, Andreasen N, Hofmann-Kiefer K, DeBernardis J, Kerkman D, McCulloch C, Kohnken R, Padberg F, Pirttilä T, Schapiro MB, Rapoport SI, Möller HJ, Davies P, Hampel H.

Arch Neurol. 2002 Aug;59(8):1267-72.

PMID:
12164722
6.

High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands.

Rizzu P, Van Swieten JC, Joosse M, Hasegawa M, Stevens M, Tibben A, Niermeijer MF, Hillebrand M, Ravid R, Oostra BA, Goedert M, van Duijn CM, Heutink P.

Am J Hum Genet. 1999 Feb;64(2):414-21.

7.

Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.

Grossman M, Farmer J, Leight S, Work M, Moore P, Van Deerlin V, Pratico D, Clark CM, Coslett HB, Chatterjee A, Gee J, Trojanowski JQ, Lee VM.

Ann Neurol. 2005 May;57(5):721-9.

PMID:
15852395
8.

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.

Hampel H, Buerger K, Zinkowski R, Teipel SJ, Goernitz A, Andreasen N, Sjoegren M, DeBernardis J, Kerkman D, Ishiguro K, Ohno H, Vanmechelen E, Vanderstichele H, McCulloch C, Moller HJ, Davies P, Blennow K.

Arch Gen Psychiatry. 2004 Jan;61(1):95-102.

PMID:
14706948
9.

Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations.

Fabre SF, Forsell C, Viitanen M, Sjögren M, Wallin A, Blennow K, Blomberg M, Andersen C, Wahlund LO, Lannfelt L.

Exp Neurol. 2001 Apr;168(2):413-8.

PMID:
11259129
10.

The genetic and pathological classification of familial frontotemporal dementia.

Morris HR, Khan MN, Janssen JC, Brown JM, Perez-Tur J, Baker M, Ozansoy M, Hardy J, Hutton M, Wood NW, Lees AJ, Revesz T, Lantos P, Rossor MN.

Arch Neurol. 2001 Nov;58(11):1813-6.

PMID:
11708988
11.

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttilä T.

Arch Neurol. 2009 Mar;66(3):382-9. doi: 10.1001/archneurol.2008.596.

PMID:
19273758
12.

Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia.

Poorkaj P, Grossman M, Steinbart E, Payami H, Sadovnick A, Nochlin D, Tabira T, Trojanowski JQ, Borson S, Galasko D, Reich S, Quinn B, Schellenberg G, Bird TD.

Arch Neurol. 2001 Mar;58(3):383-7.

PMID:
11255441
13.

CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls.

Pijnenburg YA, Janssen JC, Schoonenboom NS, Petzold A, Mulder C, Stigbrand T, Norgren N, Heijst H, Hack CE, Scheltens P, Teunissen CE.

Dement Geriatr Cogn Disord. 2007;23(4):225-30. Epub 2007 Feb 9.

PMID:
17290105
14.

Phenotypic variation in hereditary frontotemporal dementia with tau mutations.

van Swieten JC, Stevens M, Rosso SM, Rizzu P, Joosse M, de Koning I, Kamphorst W, Ravid R, Spillantini MG, Niermeijer, Heutink P.

Ann Neurol. 1999 Oct;46(4):617-26.

PMID:
10514099
15.

Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease.

Schoonenboom NS, Pijnenburg YA, Mulder C, Rosso SM, Van Elk EJ, Van Kamp GJ, Van Swieten JC, Scheltens P.

Neurology. 2004 May 11;62(9):1580-4.

PMID:
15136685
16.

Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease.

Green AJ, Harvey RJ, Thompson EJ, Rossor MN.

Neurosci Lett. 1999 Jan 8;259(2):133-5.

PMID:
10025576
17.

[Genetics of frontotemporal dementia and alterations of the tau gene].

Oliva R.

Neurologia. 2000 Jan;15 Suppl 1:33-7. Spanish.

PMID:
10723173
18.

Tau pathology in a family with dementia and a P301L mutation in tau.

Mirra SS, Murrell JR, Gearing M, Spillantini MG, Goedert M, Crowther RA, Levey AI, Jones R, Green J, Shoffner JM, Wainer BH, Schmidt ML, Trojanowski JQ, Ghetti B.

J Neuropathol Exp Neurol. 1999 Apr;58(4):335-45.

PMID:
10218629
19.

Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.

Riemenschneider M, Wagenpfeil S, Diehl J, Lautenschlager N, Theml T, Heldmann B, Drzezga A, Jahn T, Förstl H, Kurz A.

Neurology. 2002 Jun 11;58(11):1622-8.

PMID:
12058089
20.

Supplemental Content

Support Center